Peer-Reviewed Publication

Cell Reports: Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium

View

Peer-Reviewed Publication

Science: Broadly neutralizing antibodies target the coronavirus fusion peptide

View

Peer-Reviewed Publication

Cell Reports: LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

View

Peer-Reviewed Publication

Nature: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

View

Peer-Reviewed Publication

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

View

Peer-Reviewed Publication

Absci achieves a breakthrough in AI drug creation

View

Peer-Reviewed Publication

Healthy humans can be a source of antibodies countering COVID-19

View

Peer-Reviewed Publication

Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries

View

Peer-Reviewed Publication

High-Throughput Surface Plasmon Resonance Biosensors for Identifying Diverse Therapeutic Monoclonal Antibodies

View

Peer-Reviewed Publication

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

View

Peer-Reviewed Publication

Science: Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

View

Peer-Reviewed Publication

Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential

View

Peer-Reviewed Publication

Presence and Strength of Binding of IgM, IgG and IgA Antibodies Against SARS-CoV-2 During COVID-19 Infection

View

Peer-Reviewed Publication

High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during COVID-19 infection

View